Aspira Pathlab & Diagnostics Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1002885,
    "name": "Aspira Pathlab",
    "stock_name": "Aspira Pathlab",
    "full_name": "Aspira Pathlab & Diagnostics Ltd",
    "name_url": "stocks-analysis/aspira-pathlab",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "104.80",
    "chg": -2.1,
    "chgp": "-1.96%",
    "dir": -1,
    "prev_price": "106.90",
    "mcapval": "110.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 540788,
    "symbol": "",
    "ind_name": "Healthcare Services",
    "ind_code": 94,
    "indexname": "India SENSEX",
    "isin": "INE500C01017",
    "curr_date": "Aug 10",
    "curr_time": "",
    "bse_nse_vol": 1,
    "exc_status": "Active",
    "traded_date": "Aug 10, 2026",
    "traded_date_str": "2026 08 10",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/aspira-pathlab-1002885-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Broad-Based Technical Strength Lifts Aspira Pathlab & Diagnostics Ltd to 52-Week High of Rs 109",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aspira-pathlab-diagnostics-ltd-hits-new-52-week-high-of-rs109-4000524",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AspiraPathlabDi_priceRelatedfactors_4000524.png",
        "date": "2026-05-20 09:40:48",
        "description": "With a remarkable 70.29% gain over the past seven days, Aspira Pathlab &amp; Diagnostics Ltd surged to a fresh 52-week high of Rs 109 on 20 Jun 2026, defying the broader market's subdued tone and showcasing a powerful technical momentum that has captivated attention."
      },
      {
        "title": "When is the next results date for Aspira Pathlab & Diagnostics Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-aspira-pathlab-diagnostics-ltd-3999789",
        "imagepath": "",
        "date": "2026-05-19 23:18:48",
        "description": "The next results date for Aspira Pathlab & Diagnostics Ltd is scheduled for 23 May 2026...."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Aspira Pathlab & Diagnostics Ltd to 52-Week High of Rs 104.52",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aspira-pathlab-diagnostics-ltd-hits-new-52-week-high-at-rs10452-3998579",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AspiraPathlabDi_priceRelatedfactors_3998579.png",
        "date": "2026-05-19 09:41:08",
        "description": "With a sustained six-day rally delivering a 63.85% gain, Aspira Pathlab &amp; Diagnostics Ltd surged to a fresh 52-week high of Rs 104.52 on 19 Jun 2026, outpacing its healthcare services peers and the broader market."
      },
      {
        "title": "Aspira Pathlab & Diagnostics Ltd Upgraded to Sell on Technical Improvements Despite Valuation Concerns",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/aspira-pathlab-diagnostics-ltd-upgraded-to-sell-on-technical-improvements-despite-valuation-concerns-3998414",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AspiraPathlabDi_mojoScore_3998414.png",
        "date": "2026-05-19 09:00:01",
        "description": "Aspira Pathlab & Diagnostics Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 18 May 2026, driven primarily by a shift in technical indicators. However, valuation metrics and financial trends continue to weigh on the stock’s outlook, reflecting a complex investment case amid mixed signals from market data and company fundamentals."
      },
      {
        "title": "Aspira Pathlab & Diagnostics Ltd: Valuation Shift Signals Price Attractiveness Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aspira-pathlab-diagnostics-ltd-valuation-shift-signals-price-attractiveness-decline-3997882",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AspiraPathlabDi_valuationdot_3997882.png",
        "date": "2026-05-19 08:02:24",
        "description": "Aspira Pathlab & Diagnostics Ltd has witnessed a notable shift in its valuation parameters, moving from a fair to an expensive rating, prompting investors to reassess its price attractiveness amid strong recent returns and a micro-cap status within the healthcare services sector."
      },
      {
        "title": "Aspira Pathlab & Diagnostics Ltd Hits New 52-Week High of Rs 81.21 on Back of Strong Technical Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aspira-pathlab-diagnostics-ltd-hits-new-52-week-high-at-rs8121-3989053",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AspiraPathlabDi_priceRelatedfactors_3989053.png",
        "date": "2026-05-13 09:44:03",
        "description": "Surging past its previous peaks, Aspira Pathlab & Diagnostics Ltd reached a fresh 52-week high of Rs 81.21 on 13 May 2026, marking a significant milestone in its price momentum. This advance comes amid a backdrop of strong technical alignment and sustained upward price action over recent sessions."
      }
    ],
    "total": 15,
    "sid": "1002885",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/aspira-pathlab-diagnostics-1002885"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Approval Of Un-Audited Financial Result (Standalone) For The First Quarter Ended On June 302026 And To Transact Other Businesses",
      "datetime": "06-Aug-2026",
      "details": "Aspira Pathlab & Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 inter alia to consider and approve 1.Unaudited Financial Result(Standalone) along with Limited Review Report for the First Quarter ended June 30 2026 To consider evaluate and if deem fit to approve the proposal for raising of funds by way of issuance via various mode and to transact Other Businesses.",
      "source": "BSE"
    },
    {
      "caption": "Resignation Of Internal Auditor",
      "datetime": "03-Aug-2026",
      "details": "Enclosed herewith Resignation of M/s Vishal J Bhanushali and Associated with effect from 13th August 2026",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Resignation of Director",
      "datetime": "03-Aug-2026",
      "details": "Enclosed herewith Resignation of Pankaj jashwant Shah (DIN:02836324)",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "12 Aug 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Broad-Based Technical Strength Lifts Aspira Pathlab & Diagnostics Ltd to 52-Week High of Rs 109

2026-05-20 09:40:48

With a remarkable 70.29% gain over the past seven days, Aspira Pathlab & Diagnostics Ltd surged to a fresh 52-week high of Rs 109 on 20 Jun 2026, defying the broader market's subdued tone and showcasing a powerful technical momentum that has captivated attention.

When is the next results date for Aspira Pathlab & Diagnostics Ltd?

2026-05-19 23:18:48

The next results date for Aspira Pathlab & Diagnostics Ltd is scheduled for 23 May 2026....

Broad-Based Technical Strength Lifts Aspira Pathlab & Diagnostics Ltd to 52-Week High of Rs 104.52

2026-05-19 09:41:08

With a sustained six-day rally delivering a 63.85% gain, Aspira Pathlab & Diagnostics Ltd surged to a fresh 52-week high of Rs 104.52 on 19 Jun 2026, outpacing its healthcare services peers and the broader market.

Aspira Pathlab & Diagnostics Ltd Upgraded to Sell on Technical Improvements Despite Valuation Concerns

2026-05-19 09:00:01

Aspira Pathlab & Diagnostics Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 18 May 2026, driven primarily by a shift in technical indicators. However, valuation metrics and financial trends continue to weigh on the stock’s outlook, reflecting a complex investment case amid mixed signals from market data and company fundamentals.

Aspira Pathlab & Diagnostics Ltd: Valuation Shift Signals Price Attractiveness Decline

2026-05-19 08:02:24

Aspira Pathlab & Diagnostics Ltd has witnessed a notable shift in its valuation parameters, moving from a fair to an expensive rating, prompting investors to reassess its price attractiveness amid strong recent returns and a micro-cap status within the healthcare services sector.

Aspira Pathlab & Diagnostics Ltd Hits New 52-Week High of Rs 81.21 on Back of Strong Technical Signals

2026-05-13 09:44:03

Surging past its previous peaks, Aspira Pathlab & Diagnostics Ltd reached a fresh 52-week high of Rs 81.21 on 13 May 2026, marking a significant milestone in its price momentum. This advance comes amid a backdrop of strong technical alignment and sustained upward price action over recent sessions.

View All News